<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1031</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>7596443</PubmedId>
            <Abstract>Haemagglutinin (HA) is the influenza surface glycoprotein that interacts with infectivity-neutralizing antibodies. As a consequence of this immune pressure, it is the variable virus component, which is important in antigenic drift, that results in recurrent epidemics of influenza. We have determined the crystallographic structure of a complex formed between the antigen-binding fragment (Fab) of a neutralizing antibody and the membrane-distal domain ('HA top') of a HA subunit prepared from HA in its membrane-fusion-active conformation. A dramatic change is seen in the structure of the Fab-combining site on complex formation. Our results indicate that neutralization of infectivity by this antibody involves the inhibition of receptor binding, and demonstrate how influenza virus can maintain its conserved receptor-binding site despite the immune selective pressure for change in this region of the molecule; they also contribute to a complete description of the endosomal pH-induced fusion-active HA structure.</Abstract>
            <ArticleYear>1995</ArticleYear>
            <ArticlePages>92-4</ArticlePages>
            <ArticleTitle>Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Bizebard</LastName>
                    <ForeName>T</ForeName>
                </Author>
                <Author>
                    <LastName>Gigant</LastName>
                    <ForeName>B</ForeName>
                </Author>
                <Author>
                    <LastName>Rigolet</LastName>
                    <ForeName>P</ForeName>
                </Author>
                <Author>
                    <LastName>Rasmussen</LastName>
                    <ForeName>B</ForeName>
                </Author>
                <Author>
                    <LastName>Diat</LastName>
                    <ForeName>O</ForeName>
                </Author>
                <Author>
                    <LastName>Bösecke</LastName>
                    <ForeName>P</ForeName>
                </Author>
                <Author>
                    <LastName>Wharton</LastName>
                    <ForeName>S A</ForeName>
                </Author>
                <Author>
                    <LastName>Skehel</LastName>
                    <ForeName>J J</ForeName>
                </Author>
                <Author>
                    <LastName>Knossow</LastName>
                    <ForeName>M</ForeName>
                </Author>
            </Authors>
            <Affiliations>Laboratoire de Biologie Structurale, UMR 9920, CNRS-Université Paris-Sud, Gif-sur-Yvette, France.</Affiliations>
            <ArticleChemicalList>Antibodies, Viral;Hemagglutinin Glycoproteins, Influenza Virus;Hemagglutinins, Viral;Immunoglobulin Fab Fragments</ArticleChemicalList>
            <ArticleMeshHeadingsList>Antibodies, Viral(chemistry; immunology); Computer Graphics; Crystallography, X-Ray; Hemagglutinin Glycoproteins, Influenza Virus; Hemagglutinins, Viral(chemistry; immunology); Immunoglobulin Fab Fragments(chemistry); Molecular Sequence Data; Neutralization Tests; Orthomyxoviridae(chemistry; immunology); Protein Conformation</ArticleMeshHeadingsList>
            <Journal>
                <Volume>376</Volume>
                <Issue>6535</Issue>
                <Title>Nature</Title>
                <Issn>1476-4687</Issn>
                <MedlineTa>Nature</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>HC19 Fab epitope on influenza X31 hemagglutinin HA1 chain</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>T147, G150, S152, S161, W169, T171, K172, S173, G174, E206, S209, L210, L242</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>ACU79926.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>518968</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>PDB 2VIR</LocationOfData>
                <EpitopeId>548909</EpitopeId>
                <ReferenceRegion>T131, G134, S136, S145, W153, T155, K156, S157, G158, E190, S193, L194, L226</ReferenceRegion>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope residues were calculated from [PDB: 2VIR] as the antigen residues at 4Å atomic distance from the antibody. The epitope overlaps sialic acid receptor-binding site of hemagglutinin.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 1, 2, Tables 1, 2 and PDB 2VIR</LocationOfData>
                        <BCellId>14759</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P03438.2</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>132504</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The monoclonal antibody was previously described in the cited reference: Bizebard et al. (1990) J Mol Biol  216(3):513-514 [PMID: 2258927]. The details of the immunization procedure were not described. MAb HC19 is directed against hemagglutinin from strain X31 [Influenza A virus (A/Hong Kong/1/1968(H3N2))].</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3.25</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The epitope of HC19 Fab on X31 HA1 was determined from the crystal structure of the complex.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>HC19</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Lambda</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>HC19</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1GIG_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1GIG_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Membrane-distal domain of HA1 chain, 'HA top'</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TLCLGHHAVPNGTLVKTITDDQIEVTNATELVQSSSTGKICNNPHRILDGIDCTLIDALLGDPHCDVFQNETWDLFVERSKAFSNCYPYDVPDYASLRSLVASSGTLEFITEGFTWTGVTQNGGSNACKRGPGSGFFSRLNWLTKSGSTYPVLNVTMPNNDNFDKLYIWGIHHPSTNQEQTSLYVQASGRVTVSTRRSQQTIIPNIGSRPWVRGLSSRISIYWTIVKPGDVLVINSNGNLIAPRGYFKMRTGKSSIMRSDAPIDTCISECITPNGSIPNDKPFQNVNKITYGACPKYVKQN</LinearSequence>
                                        <StartingPosition>28</StartingPosition>
                                        <EndingPosition>328</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>ACU79926.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>518968</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>2VIR</ComplexPdbId>
                            <AntibodyChain1PdbChain>B</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>A</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>C</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>The structure of the HC19-combining site changes significantly on complex formation in comparison with free HC19 [PDB: 1GIG]. Another paper [PMID: 9461077] also describes this structure and two complexes of HC19 Fab with a mutant 'HA top', however, it does not provide epitope residues. The paper curated here is not a primary citation of this structure in the PDB.</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>C: T131, G134, S136, S145, W153, T155, K156, S157, G158, E190, S193, L194, L226</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>A: ; B: ;</AntibodyResiduesInteractingWithAntigen>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>C: G129, V130, T131, Q132, N133, G134, G135, S136, N137, T155, K156, S157, G158, S159, E190, S193, L194</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>A: N96; B: L28, I30, S31, W52, A53, G54, N56, N58, Y100, Y102, D103, F105, Y107</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>612.0</ContactAreaForAntigen>
                                <ContactAreaForAntibody>651.6</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

